IgA antibody dynamics in healthcare workers after CoronaVac® vaccination and heterologous Comirnaty® booster dose

Braz J Microbiol. 2023 Jun;54(2):921-927. doi: 10.1007/s42770-023-00935-1. Epub 2023 Mar 2.

Abstract

Background: This study is aimed at calculating the IgA antibody dynamic range in healthcare workers (HCWs) after immunization with CoronaVac® and Comirnaty® booster dose.

Methods: A total of 118 HCW serum samples from Southern Brazil were collected the day before the first vaccine dose (day 0) and + 20, + 40, + 110, + 200 days following the vaccine's first dose, and + 15 days after a Comirnaty® booster dose. Immunoglobulin A (IgA) was quantified using immunoassays for anti-S1 (spike) protein antibodies (Euroimmun, Lübeck, Germany).

Results: Seroconversion for the S1 protein occurred in 75 (63.56%) and 115 (97.47%) HCWs by day + 40 and day + 15 after the booster dose, respectively. There was an absence of IgA antibodies after the booster dose in two (1.69%) HCWs undergoing biannual rituximab administration and one (0.85%) HCW for no apparent reason.

Conclusion: Complete vaccination showed a significant IgA antibody production response, and the booster dose considerably increased this response.

Keywords: Immunization; Immunoglobulin A; Pandemic; Public health; SARS-CoV-2; Vaccine.

MeSH terms

  • Antibodies, Viral
  • BNT162 Vaccine*
  • Health Personnel
  • Humans
  • Immunoglobulin A
  • Vaccination*

Substances

  • sinovac COVID-19 vaccine
  • BNT162 Vaccine
  • Immunoglobulin A
  • Antibodies, Viral